Beam Global (BEEM) 10-Q 14 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 13, 2019
Document And Entity Information
Entity Registrant Name	Envision Solar International, Inc.
Entity Central Index Key	0001398805
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		5,140,546
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2019
Entity Interactive Data Current	Yes
Entity Incorporation State County Code	NV
Entity File Number	000-53204

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current Assets
Cash	$ 5,292,229	$ 244,024
Accounts Receivable, net	1,069,827	1,290,702
Prepaid and other current assets	205,028	256,071
Inventory, net	1,695,919	1,130,966
Total Current Assets	8,263,003	2,921,763
Property, Plant and Equipment, net	530,650	133,235
Other Assets
Patents, net	170,782	131,625
Deposits	56,869	105,541
Deferred Equity Offering Costs	0	195,028
Total Other Assets	227,651	432,194
Total Assets	9,021,304	3,487,192
Current Liabilities
Accounts Payable	713,443	1,368,257
Accrued Expenses	823,937	614,170
Sales Tax Payable	133,402	191
Deferred Revenue	86,677	835,785
Convertible note payable - related party, net of debt discount of $7,488 at September 30, 2019	212,929	0
Convertible Line of Credit	0	960,000
Convertible notes payable, net of discount of $446,381 at December 31, 2018	0	1,104,235
Note payable, net of discount of $74,315 at December 31, 2018	0	788,185
Auto Loan - Current Portion	11,014	10,520
Total Current Liabilities	1,981,402	5,681,343
Long-term Liabilities
Convertible note payable - related party, net of debt discount of $7,749 at December 31, 2018	0	177,251
Convertible notes payable - Long Term Portion	0	100,000
Long-term portion of Auto Loan	940	9,277
Total Long Term Liabilities	940	286,528
Total Liabilities	1,982,342	5,967,871
Commitments and Contingencies (Note 10)
Stockholders' Deficit
Preferred stock, $0.001 par value, 10,000,000 authorized, 0 outstanding as of September 30, 2019 and December 31, 2018, respectively.	0	0
Common stock, $0.001 par value, 9,800,000 shares authorized, 5,140,546 and 2,906,630 shares issued or issuable and outstanding at September 30, 2019 and December 31, 2018, respectively.	5,140	2,907
Additional Paid-in-Capital	51,453,349	39,392,073
Accumulated Deficit	(44,419,527)	(41,875,659)
Total Stockholders' Equity (Deficit)	7,038,962	(2,480,679)
Total Liabilities and Stockholders' Equity (Deficit)	$ 9,021,304	$ 3,487,192

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Preferred stock, par value	$ .001	$ .001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common Stock par value (in Dollars per share)	$ .001	$ 0.001
Common Stock shares authorized	9,800,000	9,800,000
Common Stock shares issued	5,140,546	2,906,630
Common Stock shares outstanding	5,140,546	2,906,630
Convertible Notes Payable [Member]
Unamortized discount		$ 446,381
Convertible Notes Payable [Member] | Related Party [Member]
Unamortized discount	$ 7,488	7,749
Note Payable [Member]
Unamortized discount		$ 74,315

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Revenues	$ 1,785,724	$ 938,218	$ 4,615,669	$ 4,658,685
Cost of Revenues	1,444,887	894,068	4,266,389	4,561,501
Gross Profit	340,836	44,150	349,279	97,184
Operating Expenses (including stock based compensation expense of $229,592 and $219,277 for the nine months ended September 30, 2019 and 2018, respectively)	963,487	519,468	2,226,667	1,701,788
Loss From Operations	(622,651)	(475,318)	(1,877,388)	(1,604,604)
Other Income (Expense)
Interest income	21,739	818	45,768	2,240
Gain on sale of fixed asset	0	16,260	0	16,260
Interest Expense	(7,182)	(148,316)	(709,148)	(806,330)
Total Other Income (Expense)	14,557	(131,238)	(663,380)	(787,830)
Loss Before Tax Expense	(608,094)	(606,556)	(2,540,768)	(2,392,434)
Tax Expense	2,269	0	3,100	0
Net Loss	$ (610,363)	$ (606,556)	$ (2,543,868)	$ (2,392,434)
Net Loss Per Share - Basic and Diluted	$ (0.12)	$ (0.21)	$ (0.60)	$ (0.83)
Weighted Average Shares Outstanding - Basic and Diluted	5,114,296	2,897,880	4,220,398	2,887,371

Condensed Statements of Opera_2

Condensed Statements of Operations (Unaudited) (Parenthetical) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Stock based compensation	$ 229,592	$ 219,277

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders' Equity Deficit (unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	2,836,713
Beginning balance, value at Dec. 31, 2017	$ 2,837	$ 37,924,780	$ (38,276,879)	$ (349,262)
Stock issued for cash, shares	38,667
Stock issued for cash, value	$ 38	289,962		290,000
Cash Offering Costs		(12,000)		(12,000)
Stock issued for Director Services, shares	18,750
Stock issued for Director Services, value	$ 19	140,606		140,625
Value of Warrants and Benefical Conversion Features Related to Debt Instruments		212,420		212,420
Stock Option Expense		4,342		4,342
Net Loss			(1,011,607)	(1,011,607)
Ending balance, shares at Mar. 31, 2018	2,894,130
Ending balance, value at Mar. 31, 2018	$ 2,894	38,560,110	(39,288,486)	(725,482)
Beginning balance, shares at Dec. 31, 2017	2,836,713
Beginning balance, value at Dec. 31, 2017	$ 2,837	37,924,780	(38,276,879)	(349,262)
Net Loss				(2,392,434)
Ending balance, shares at Sep. 30, 2018	2,902,880
Ending balance, value at Sep. 30, 2018	$ 2,903	38,780,891	(40,669,313)	(1,885,519)
Beginning balance, shares at Mar. 31, 2018	2,894,130
Beginning balance, value at Mar. 31, 2018	$ 2,894	38,560,110	(39,288,486)	(725,482)
Stock issued for Director Services, shares	3,750
Stock issued for Director Services, value	$ 4	28,121		28,125
Recording of debt discount		30,960		30,960
Stock Option Expense		4,342		4,342
Net Loss			(774,271)	(774,271)
Ending balance, shares at Jun. 30, 2018	2,897,880
Ending balance, value at Jun. 30, 2018	$ 2,898	38,623,533	(40,062,757)	(1,436,326)
Stock issued for Director Services, shares	5,000
Stock issued for Director Services, value	$ 5	37,495		37,500
Recording of debt discount		115,521		115,521
Stock Option Expense		4,342		4,342
Net Loss			(606,556)	(606,556)
Ending balance, shares at Sep. 30, 2018	2,902,880
Ending balance, value at Sep. 30, 2018	$ 2,903	38,780,891	(40,669,313)	(1,885,519)
Beginning balance, shares at Dec. 31, 2018	2,906,630
Beginning balance, value at Dec. 31, 2018	$ 2,907	39,392,073	(41,875,659)	(2,480,679)
Stock issued for Director Services, shares	3,750
Stock issued for Director Services, value	$ 3	31,247		31,250
Value of Warrants and Benefical Conversion Features Related to Debt Instruments		3,967		3,967
Stock Option Expense		2,301		2,301
Net Loss			(949,631)	(949,631)
Ending balance, shares at Mar. 31, 2019	2,910,380
Ending balance, value at Mar. 31, 2019	$ 2,910	39,429,588	(42,825,290)	(3,392,792)
Beginning balance, shares at Dec. 31, 2018	2,906,630
Beginning balance, value at Dec. 31, 2018	$ 2,907	39,392,073	(41,875,659)	(2,480,679)
Net Loss				(2,543,868)
Ending balance, shares at Sep. 30, 2019	5,140,546
Ending balance, value at Sep. 30, 2019	$ 5,140	51,453,349	(44,419,527)	7,038,962
Beginning balance, shares at Mar. 31, 2019	2,910,380
Beginning balance, value at Mar. 31, 2019	$ 2,910	39,429,588	(42,825,290)	(3,392,792)
Stock issued for cash, shares	2,200,000
Stock issued for cash, value	$ 2,200	13,195,800		13,198,000
Cash Offering Costs		(1,370,879)		(1,370,879)
Stock issued for Director Services, shares	3,750
Stock issued for Director Services, value	$ 4	31,246		31,250
Warrants Issued for Cash		3,000		3,000
Stock Option Expense		1,531		1,531
Fractional Share Cash Payment, shares	(21)
Fractional Share Cash Payment, value		(171)		(171)
Fractional Shares Issued from Reverse Split	187
Net Loss			(983,874)	(983,874)
Ending balance, shares at Jun. 30, 2019	5,114,296
Ending balance, value at Jun. 30, 2019	$ 5,114	51,290,115	(43,809,164)	7,486,065
Stock issued for Director Services, shares	26,250
Stock issued for Director Services, value	$ 26	154,974		155,000
Stock Option Expense		8,260		8,260
Net Loss			(610,363)	(610,363)
Ending balance, shares at Sep. 30, 2019	5,140,546
Ending balance, value at Sep. 30, 2019	$ 5,140	$ 51,453,349	$ (44,419,527)	$ 7,038,962

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$ (2,543,868)	$ (2,392,434)
Adjustments to Reconcile Net loss to Net Cash Used in Operating Activities:
Depreciation and Amortization	30,018	51,816
Common Stock Issued for Services	217,500	206,250
Gain on Sale of Fixed Assets	0	(16,260)
Compensation Expense Related to Grant of Stock Options	12,092	13,026
Amortization of Debt Discount	524,925	651,638
(Increase) decrease in:
Accounts Receivable	220,875	(787,746)
Prepaid Expenses and Other Current Assets	(490,264)	(315,285)
Inventory	(3,670)	1,609,828
Deposits	48,672	51,047
Increase (decrease) in:
Accounts Payable	(654,814)	259,938
Accrued Expenses	(225,268)	31,880
Convertible Note Payable Issued in Lieu of Salary - Related Party	35,417	37,500
Sales Tax Payable	133,211	46,579
Deferred Revenue	(749,108)	143,088
NET CASH USED IN OPERATING ACTIVITIES	(3,444,282)	(409,135)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(9,977)	0
Sale of equipment	0	50,267
Funding of patent costs	(41,554)	(56,065)
NET CASH USED IN INVESTING ACTIVITIES	(51,531)	(5,798)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Sale of Common Stock	0	290,000
Payments of Offering Costs Related to Sale of Common Stock	0	(12,000)
Borrowings (Repayments) on Convertible Line of Credit, Net	(960,000)	(626,220)
Repayments of Convertible Notes Payable, Net	(1,650,616)	(9,000)
Borrowings (Repayments) of Note Payable	(862,500)	750,000
Repayments of Auto Loan	(7,843)	(8,185)
Payments of loan offering costs	0	(5,000)
Payments of Deferred Equity Offering Costs	(1,175,852)	(113,197)
Fractional Share Payments	(171)	0
Proceeds from Issuance of Common Stock and Warrants, Pursuant to Public Offering	13,201,000	0
NET CASH PROVIDED BY FINANCING ACTIVITIES	8,544,018	266,398
NET INCREASE (DECREASE) IN CASH	5,048,205	(148,535)
CASH AT BEGINNING OF PERIOD	244,024	403,475
CASH AT END OF PERIOD	5,292,229	254,940
Supplemental Disclosure of Cash Flow Information:
Cash paid for interest	363,899
Cash paid for income tax	3,100
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Recording of debt discount	3,967
Transfer of prepaid asset to inventory	541,307
Recording of right of use asset and corresponding liability	872,897
Depreciation capitalized into inventory	19,976
Reclassification of deferred equity offering costs to APIC	195,027
Recording of payment premium on note payable	$ 0	$ 37,500

1. NATURE OF OPERATIONS, BASIS

1. NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Envision Solar International, Inc., a Nevada corporation (hereinafter the “Company,” “us,” “we,” “our” or “Envision”) is a sustainable technology innovation company based in San Diego, California. Focusing on what we refer to as “Solar 3.0,” we invent, design, engineer, manufacture and sell solar powered products that enable vital and highly valuable services in locations where it is either too expensive or too impactful to connect to the utility grid, or where the requirements for electrical power are so important that grid failures, like blackouts, are intolerable. When competing with utilities or typical solar companies, we rely on our products’ ease of deployment, reliability, accessibility, and total cost of ownership, rather than producing the cheapest kilowatt hour with the help of subsidies. Envision’s products and proprietary technology solutions target three markets that are experiencing significant growth with annual global spending in the billions of dollars: · electric vehicle charging infrastructure; · out of home advertising platforms; and · energy security and disaster preparedness. The Company focuses on creating renewably energized, high-quality products for electric vehicle (“EV”) charging, outdoor media and branding, and energy security that are rapidly deployable and attractively designed. Basis of Presentation The interim unaudited condensed financial statements included herein have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission. In management’s opinion, all adjustments (consisting of normal recurring adjustments and reclassifications) necessary to present fairly our results of operations and cash flows for the three and nine months ended September 30, 2019 and 2018, and our financial position as of September 30, 2019, have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual financial statements have been condensed or omitted from these interim financial statements. Accordingly, these interim unaudited condensed financial statements should be read in conjunction with the financial statements and notes thereto for the year ended December 31, 2018. The December 31, 2018 balance sheet is derived from those statements. Reverse Stock Split The Company completed a 1 for 50 reverse split of our common stock in April 2019, and all share and per share data in the accompanying unaudited financial statements and footnotes for all periods presented have been retroactively adjusted for this reverse stock split. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying unaudited condensed consolidated financial statements include the allowance for doubtful accounts receivable, valuation of inventory and cost allocations, depreciable lives of property and equipment, estimates of loss contingencies, estimates of the valuation of initial right of use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of share-based expense, and the valuation allowance on deferred tax assets. Concentrations Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist of cash and accounts receivable. The Company maintains its cash in banks and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts from inception through September 30, 2019. As of September 30, 2019, $4,885,821 of the Company’s cash deposits were greater than the federally insured limits. Major Customers For the three months ended September 30, 2019, revenues from two customers accounted for 62% and 14% of total revenues, and for the nine months ended September 30, 2019, revenues from two customers accounted for 49% and 24% of total revenues, with no other single customer accounting for more than 10% of revenues. At September 30, 2019, accounts receivable from three customers accounted for 47%, 25% and 14% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. For the three months ended September 30, 2018, revenues from three customers accounted for 33%, 20% and 19% of total revenues, and for the nine months ended September 30, 2018, revenues from one customer accounted for 43%, with no other single customer accounting for more than 10% of revenues. At September 30, 2018, accounts receivable from three customers accounted for 42%, 25% and 13% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. Major Suppliers The Company currently has one source from which it procures its batteries for use in its products. To help mitigate the risk of supply or quality issues that could impact production, the Company has identified additional sources of supply and is qualifying them for use in the future to mitigate any supply risk. Cash and Cash Equivalents For the purposes of the unaudited condensed statements of cash flows, the Company considers all liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at September 30, 2019 and December 31, 2018 respectively. Fair Value of Financial Instruments The Company’s financial instruments, including accounts receivable, accounts payable, accrued expenses, and short-term loans, are carried at historical cost basis. At September 30, 2019, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments. Accounts Receivable Accounts receivable are customer obligations due under normal trade terms. Management reviews accounts receivable on a periodic basis to determine if any receivables may become uncollectible. Management’s evaluation includes several factors including the aging of the accounts receivable balances, a review of significant past due accounts, dialogue with the customer, the financial profile of a customer, our historical write-off experience, net of recoveries, and economic conditions. The Company includes any accounts receivable balances that are determined to be uncollectible in its overall allowance for doubtful accounts. Further, the Company may record a general reserve in its allowance for doubtful accounts to account for future changes that may negatively impact our overall collections. After all attempts to collect a receivable have failed, the receivable is written off against the allowance. Inventory Inventory is stated at the lower of cost and net realizable value. Cost is determined using the first-in, first-out method of accounting. Inventory costs primarily relate to purchased raw materials and components used in the manufacturing of our products, work in process for products being manufactured, and finished goods. Included in these costs are direct labor and certain manufacturing overhead costs associated with the manufacturing process. The Company regularly reviews inventory components and quantities on hand and performs annual physical inventory counts. A reserve is established if this review process determines the net realizable value of such inventory may be below the carrying value. Patents The Company believes it will achieve future economic value benefits for its various patents and patent ideas. All administrative costs for obtaining patents are accumulated on the balance sheet as a Patent asset until such time as a patent is issued. The costs of these intangible assets are classified as a long-term asset and amortized on a straight line basis over the legal life of such asset, which is typically 20 years. In the event a patent is denied or abandoned, all accumulated administrative costs will be expensed in the period in which the patent was denied or abandoned. Patent amortization expense was $2,397 and $856 in the nine-month periods ended September 30, 2019 and 2018, respectively. Leases In February 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-02: “Leases (Topic 842)” whereby lessees need to recognize almost all leases on their balance sheet as a right of use asset and a corresponding lease liability. The Company adopted this standard as of January 1, 2019 using the effective date method and applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected not to reassess the following: (i) whether any expired or existing contracts contain leases, and (ii) initial direct costs for any existing leases. For contracts entered into after the effective date, at the inception of a contract the Company will assess whether the contract is, or contains, a lease. The Company’s assessment will be based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. The Company has elected to not recognize right of use assets and lease liabilities for short term leases that have a term of 12 months or less. Monthly lease payments on our sole operating lease range from $48,672 to $50,619 through the term of the lease. We calculated the present value of the remaining lease payment stream using our effective borrowing rate of 10%. We have recorded a right-of-use asset amounting to $435,035 included in property, plant and equipment and corresponding liability included in accrued expenses amounting to $480,094 related to this lease at September 30, 2019. Revenue Recognition On January 1, 2018, Envision adopted the revenue standards of Financial Accounting Standards Board Update No. 2014-09: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation. Revenues are primarily derived from the direct sales of manufactured products. Revenues may also consist of maintenance fees for the maintenance of previously sold products and revenues from sales of professional services. Revenues from inventoried product sales are recognized upon the final delivery of such product to the customer or when legal transfer of ownership takes place. Revenue values are fixed price arrangements determined at the time an order is placed or a contract is entered into. The customer is typically obligated to make payment for such products within a 30-45 day period after delivery. Revenues from maintenance fees for services provided by the Company are recognized equally over the period of the maintenance term. Revenue values are fixed price arrangements determined at the time an order is placed or a contract is entered into. The customer is typically obligated to make payment for the service in advance of the maintenance period. Extended maintenance or warranty services, where the customer has the option to purchase this extension as a separate purchase option, are considered a separate performance obligation. If the company does not control the extended services, in terms of having the responsibility for fulfillment of the obligation or the option to choose who will perform the services, the Company is acting as an agent and would report the revenues on a net basis. Revenues from professional services are recognized as services are performed. Revenue values are based upon fixed fee arrangements or hourly fee-based arrangements with agreed to hourly rates of service categories in line with expertise requirements. These services are billed to a customer as such services are provided and the customer will be obligated to make payments for such services typically within a 30-45 day period. The Company includes shipping and handling fees billed to customers as revenues and shipping and handling costs as cost of revenues. Any deposits received from a customer prior to delivery of the purchased product or monies paid prior to the period for which a service is provided are accounted for as deferred revenue on the balance sheet. Sales tax is recorded on a net basis and excluded from revenue. The Company generally provides a standard one-year warranty on its products for materials and workmanship but may provide multiple year warranties as negotiated, and it will pass on the warranties from its vendors, if any, which generally covers this one-year period. In accordance with ASC 450-20-25, the Company accrues for product warranties when the loss is probable and can be reasonably estimated. At September 30, 2019, the Company has no product warranty accrual given the Company’s de minimis historical financial warranty expense. Cost of Revenues The Company records direct material and component costs, direct labor and associated benefits, and manufacturing overhead costs such as supervision, manufacturing equipment depreciation, rent, and utility costs, all of which are included in inventory prior to a sale, as costs of revenues. The Company further includes shipping and handling fees billed to customers as revenues and shipping and handling costs as cost of revenues. Stock-Based Compensation The Company follows ASC 718, “Compensation – Stock Compensation.” ASC 718 requires companies to estimate and recognize the fair value of stock-based awards to employees and directors. The fair value of the portion of an award that is ultimately expected to vest is recognized as an expense over the shorter of the service periods or vesting periods using the straight-line attribution method. The Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of adoption. There was no cumulative effect of adoption on January 1, 2019. The Company estimates the fair value of each stock option at the grant date by using the Black-Scholes option pricing model. Net Loss Per Share Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted net loss per common share is computed using the weighted average number of common shares outstanding for the period, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock warrants, convertible debt instruments or other common stock equivalents. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. Convertible notes payable that are convertible into 35,174 common shares, options to purchase 288,662 common shares and warrants to purchase 2,538,990 common shares were outstanding at September 30, 2019. These shares were not included in the computation of diluted loss per share for the three or nine months ended September 30, 2019 because the effects would have been anti-dilutive. These options, warrants and convertible debt embedded conversion options may dilute future earnings per share. Segments The Company follows ASC 280-10 "Disclosures about Segments of an Enterprise and Related Information." During 2019 and 2018, the Company only operated in one segment; therefore, segment information has not been presented.

2. LIQUIDITY

2. LIQUIDITY	9 Months Ended
	Sep. 30, 2019
Risks and Uncertainties [Abstract]
LIQUIDITY	2. LIQUIDITY As reflected in the accompanying unaudited condensed financial statements for the nine months ended September 30, 2019, the Company had a net loss and net cash used in operating activities of $2,543,868 and $3,444,282, respectively. Additionally, at September 30, 2019, the Company had an accumulated deficit of $44,419,527. The Company has incurred significant losses from operations since inception, and such losses are expected to continue. In April and May 2019, the Company received approximately $8.5 million of cash, net of offering costs and repayment of certain debt, under an equity offering which is more fully described in Note 11. The Company has $5.3 million in cash at September 30, 2019. With this financing, management believes it has sufficient cash to fund its liabilities and operations beyond the next twelve months from the issue date of this report.

3. INVENTORY

3. INVENTORY	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
INVENTORY	3. INVENTORY Inventory consists of the following: September 30, December 31, 2019 2018 Work in process $ 783,314 $ 443,701 Raw materials 924,029 698,689 Inventory allowance (11,424 ) (11,424 ) Total inventory $ 1,695,919 $ 1,130,966

4. ACCRUED EXPENSES

4. ACCRUED EXPENSES	9 Months Ended
	Sep. 30, 2019
Payables and Accruals [Abstract]
ACCRUED EXPENSES	4. ACCRUED EXPENSES The major components of accrued expenses are summarized as follows: September 30, December 31, 2019 2018 Lease liability $ 480,094 $ – Accrued vacation 169,061 196,888 Accrued salaries 100,141 – Accrued interest 43,389 239,838 Accrued rent – 66,349 Accrued loss contingency – 71,744 Other accrued expense 31,252 39,351 Total accrued expenses $ 823,937 $ 614,170

5. CONVERTIBLE LINE OF CREDIT

5. CONVERTIBLE LINE OF CREDIT	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
CONVERTIBLE LINE OF CREDIT	5. CONVERTIBLE LINE OF CREDIT During the quarter ended June 30, 2019, the Company used proceeds from its public offering to pay off the entire balance of a Convertible Line of Credit, along with all accrued and unpaid interest. As of September 30, 2019, the following summarizes the convertible line of credit: On September 18, 2017, in addition to a convertible “Lender” note (See Note 7), the Company entered into a revolving secured convertible promissory note (the “Revolver”) with an unaffiliated lender (the “Lender”). Pursuant to the Revolver, the Company has the right to make borrowings from the Lender in amounts of up to 70% of the value of any specific purchase order (each a “PO”) received by the Company from a credit worthy customer (each a “Draw Down”), up to a maximum of $3,000,000, commencing on the date of the Revolver and terminating December 31, 2019. The Revolver bears simple interest at the floating rate per annum equal to the 12-month USD LIBOR index rate quoted from time to time in New York, New York by the Bloomberg Service plus 600 basis points (the “Interest Rate”). The Interest Rate will be adjusted on the first day of each calendar month during the term of this Note to reflect any changes in the 12 month LIBOR rate as quoted on that day, or if that day is not a business day, on the next business day thereafter. The principal and accrued unpaid interest with respect to each Draw Down is due and payable within five (5) business days of receipt from the Customer by the Company of a payment due under the applicable PO (with respect to each Draw Down, the “Maturity Date”). Each Draw Down is secured by a perfected recorded second priority security interest in all of the Company’s assets. The Lender will have the right at any time until the Maturity Date of a Draw Down, provided the Lender gives the Company written notice of the Lender’s election to convert prior to any prepayment of such Draw Down by the Company with respect to converting that portion of such Draw Down covered by the prepayment, to convert all or any portion of the outstanding principal and accrued unpaid interest (the “Conversion Amount”), into such number of the Company’s common stock as is determined by dividing the Conversion Amount by the greater of (i) seven dollars and fifty cents ($7.50) or (ii) 75% of the Volume Weighted Average Price of the Company’s common stock that is quoted on a public securities trading market (if more than one, the one with the then highest trading volume), during the five (5) consecutive trading days immediately prior to the date of the Lender’s written notice of the Lender’s election to convert. As additional consideration for any Draw Downs made by the Company, the Company agreed to issue to the Lender common stock purchase warrants exercisable for a period of three years from the date of issuance with an exercise price equal to the greater of (i) $7.50 per share or (ii) 75% of the Volume Weighted Average Price of the Company’s common stock that is quoted on a public securities trading market (if more than one, the one with the then highest trading volume), during the five (5) consecutive trading days immediately prior to the date of the applicable Draw Down. The number of warrants issuable to the Lender will equal 25% of the increase over the highest dollar amount previously drawn down by the Company on the Revolver divided by the greater of (i) seven dollars and fifty cents ($7.50) or (ii) 75% of the Volume Weighted Average Price of the Company’s common stock that is quoted on a public securities trading market (if more than one, the one with the then highest trading volume), during the five (5) consecutive trading days immediately prior to the date of the applicable Draw Down which causes the increase over the previous highest amount borrowed. The Company received funds for an initial Draw Down on September 26, 2017 in the amount of $850,000. As a result of this Draw Down, the Company issued warrants to purchase up to 28,333 shares of common stock at an exercise price equal to $7.50 with a three-year term and having a value of $122,992 using the Black-Scholes valuation methodology. As a result of this transaction and including the relative fair value of the issued warrants, the Company recorded $243,223 of value of beneficial conversion features and warrants, which was recorded as debt discount on the accompanying balance sheet and was amortized to interest expense over the term of the Draw Down. This Draw Down was paid back to the Lender during the three-month period ended March 31, 2018. The Company received funds for a second Draw Down on October 24, 2017 in the amount of $300,000. As a result of this Draw Down, the Company issued warrants to purchase up to 10,000 shares of common stock at an exercise price equal to $7.50 with a three year term and having a value of $56,620 using the Black-Scholes valuation methodology. As a result of this transaction and including the relative fair value of the issued warrants, the Company recorded $175,261 of value of beneficial conversion features and warrants, which was recorded as debt discount on the accompanying balance sheet and was amortized to interest expense over the term of the Draw Down. This Draw Down was paid back to the Lender during the three-month period ended March 31, 2018. The Company received funds for a third Draw Down on February 20, 2018 in the amount of $290,000. As a result of this Draw Down, the Company issued warrants to purchase up to 8,156 shares of common stock at an exercise price equal to $7.50 with a three year term and having a fair value of $61,282 using the Black-Scholes valuation methodology (See Note 12). As a result of this transaction, the Company recorded $212,420 of debt discount consisting of the relative fair value of warrants of $50,591 and a beneficial conversion feature value of $161,829 which was amortized to interest expense over the term of the Draw Down. This drawn down was paid back to the Lender during the three-month period ended June 30, 2018. During the year ended December 31, 2018, the Company received other funds on Draw Downs totaling $1,513,013 and paid back Draw Downs amounting to $553,013. No warrants were issued on these Draw Downs. As of December 31, 2018, the convertible line of credit had a principal balance outstanding amounting to $960,000 with accrued interest amounting to $12,909 which is included in accrued expenses. During the three months ended March 31, 2019 the Company received other funds on Draw Downs totaling $158,442. No warrants were issued on these Draw Downs. As of March 31, 2019, the convertible line of credit had a balance amounting to $1,118,442 with accrued interest amounting to $34,705 which is included in accrued expenses. During the three months ended June 30, 2019, the Company paid back the full Draw Down balance of $1,118,442, and unpaid interest of $44,599, of which $9,893 was expensed in the quarter.

6. CONVERTIBLE NOTE PAYABLE - R

6. CONVERTIBLE NOTE PAYABLE - RELATED PARTY	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
CONVERTIBLE NOTE PAYABLE - RELATED PARTY	6. CONVERTIBLE NOTE PAYABLE - RELATED PARTY On October 18, 2016, the Company entered into a five-year employment agreement, effective as of January 1, 2016, with Mr. Desmond Wheatley, the Chief Executive Officer, President, and Chairman of the Company (the “Agreement”). Pursuant to the Agreement, Mr. Wheatley receives an annual deferred salary of $50,000 which Mr. Wheatley defers until such time as Mr. Wheatley and the Board of Directors agreed that payment of the deferred salary and/or cessation of the deferral was appropriate. In August 2018, the Agreement was amended to provide that his salary shall defer until the earliest to occur of the following: (i) a permissible event specified in Section 409A of the Code, (ii) December 31, 2020, (iii) a change of control as defined in the Agreement, or (iv) a sale of all or substantially all of the assets of the Company. All deferred amounts are evidenced by an unsecured convertible promissory note payable by the Company to Mr. Wheatley bearing simple interest at the rate of 10% per annum, accruing until paid, convertible into shares of the Company’s common stock at $7.50 per share at any time in whole or in part at Mr. Wheatley’s discretion. As the conversion price was equivalent to the fair value of the common stock at various salary deferral dates prior to June 30, 2018, there was no beneficial conversion feature to this note through such date. Subsequent to June 30, 2018 through December 31, 2018 and based on the average daily closing price of our common stock, the Company recorded $8,672 of debt discount for the beneficial conversion feature value which is being amortized to interest expense over the term of the note. For the three months ended March 31, 2019 and based on the average daily closing price of our common stock, the Company recorded $3,967 of debt discount for the beneficial conversion feature value which is also being amortized to interest expense over the term of the note. There was no beneficial conversion value and therefore, no debt discount was recorded for the three months ended June 30 or September 30, 2019. Additionally, on March 29, 2017 the Board of Directors granted Mr. Wheatley a $35,000 bonus for which Mr. Wheatley agreed to defer such bonus under the same terms of his salary deferral. The balance of the note as of September 30, 2019 is $212,929, net of debt discount amounting to $7,488, with accrued and unpaid interest amounting to $43,389 which is included in accrued expenses (See Note 4). On September 17, 2019, the Board of Directors adopted a resolution to pay off the convertible promissory note issued to Mr. Wheatley for his deferred compensation in the near future (subject to a recommendation on timing from Mr. Wheatley), and no additional salary will be deferred after September 15, 2019. As a result, this note is presented as a short-term liability on the accompanying balance sheet.

7. CONVERTIBLE NOTES PAYABLE

7. CONVERTIBLE NOTES PAYABLE	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	7. CONVERTIBLE NOTES PAYABLE During the quarter ended June 30, 2019, the Company used proceeds from its public offering to pay off the entire balances of all outstanding convertible notes payable, except for Mr. Wheatley’s convertible note as discussed in Note 6, totaling $1,650,616 in principle, and $192,191 of accrued and unpaid interest. As of September 30, 2019, the following summarizes those convertible notes payable: Pegasus Note On December 19, 2009, the Company entered into a convertible promissory note for $100,000 to a new landlord in lieu of paying rent for one year for new office space. The interest was 10% per annum with the note principal and interest originally due December 18, 2010. If the Company receives greater than $1,000,000 of proceeds from debt or equity financing, 25% of the amount in excess of $1,000,000 would be used to pay down the note. This note was subordinate to all existing senior indebtedness of the Company. This note was convertible at $16.50 per share and had no beneficial conversion feature at the note date. Through a series of amendments, the term of the note was extended until December 31, 2016, and the lender waived, through December 31, 2015, the requirement to pay down the note with financing proceeds received by the Company. Effective June 13, 2018, the Company entered into a further amendment to extend the maturity date of this note to December 31, 2019, and the lender waived the past requirements to pay the note with financing proceeds received by the Company. There were no additional fees or discounts associated with this amendment. This modification was treated as an extinguishment as the change in fair value of the embedded conversion option just before and just after the modification was more than 10% of the carrying amount of the note. The market price of the Company’s stock was below the conversion price at the time of the modification, therefore no beneficial conversion feature needed to be recorded. As of March 31, 2019, the note had a balance of $100,000 with accrued and unpaid interest amounting to $92,603. During the quarter ended June 30, 2019, the Company repaid the $100,000 note, and unpaid interest of $93,096, of which $493 was expensed in that quarter. Evey Note Prior to fiscal 2011, the Company was advanced monies by John Evey, our former director, and executed a 10% convertible promissory note with compounding interest which was convertible into shares of common stock at $16.50 per share. There was no beneficial conversion feature at the note date and this note was subordinate to the then existing notes. Through a series of amendments from the original due date, the conversion price of the convertible note was reduced to $10.00 and the maturity date was extended to December 31, 2017. Effective June 27, 2018, the Company entered into a further extension agreement to extend the maturity date of this note to July 1, 2019. There were no additional fees or discounts associated with this extension. This modification was treated as an extinguishment as the change in fair value of the embedded conversion option just before and just after the modification was more than 10% of the carrying amount of the note. The Company recorded debt discount amounting to $30,960 for the value of the beneficial conversion feature and is amortizing this to interest expense over the remaining term of the loan. As of March 31, 2019, this note had a balance, net of $7,740 of discount, amounting to $42,876 with accrued interest amounting to $76,440 which is included in accrued expenses. The note continued to bear interest at a rate of 10% . During the quarter ended June 30, 2019, the Company repaid the note balance of $50,616, and unpaid interest of $77,066, of which $627 was expensed in that quarter. In addition, the Company paid $80,000 to Mr. Evey during the quarter ended June 30, 2019 for consulting services. “Lender” Note On September 18, 2017, in addition to entering into a revolving convertible line of credit (See Note 5), the Company also entered into a $1,500,000 secured convertible promissory note with the same unaffiliated lender (the “Lender”). The Note bears simple interest at the floating rate per annum equal to the 12 month USD LIBOR index rate quoted from time to time in New York, New York by the Bloomberg Service plus 400 basis points (the “Interest Rate”). The Interest Rate will be adjusted on the first day of each calendar month during the term of the Note to reflect any changes in the 12 month LIBOR rate as quoted at on that day, or if that day is not a business day, on the next business day thereafter. Interest will only accrue on outstanding principal. Accrued unpaid interest was payable monthly on the first calendar day of each month for interest accrued during the previous month, with all outstanding principal and accrued unpaid interest originally payable in full on or before September 17, 2018 to the extent not converted into shares of the Company’s common stock. This note was initially amended to be payable in full by December 1, 2018 but the Company did not make the December 1, 2018 principal payment. In March 2019, and effective as of December 1, 2018, the Company entered into second amendment to extend the term of the note to be payable in full by (i) June 30, 2019 or (ii) the closing of the public offering by the Company. This modification was treated as a debt extinguishment as the change in fair value of the embedded conversion option just before and just after the modification was more than 10% of the carrying amount of the note. The Company recorded debt discount amounting to $472,718 for the value of the beneficial conversion feature and is amortizing this to interest expense over the remaining term of the note. Additionally, the Company paid $30,000 of lender fees which were also recorded as debt discount and are also being amortized to interest expense over the term of the note. The Note is secured by a perfected recorded first priority security interest in all of the Company’s assets, as set forth in a certain Security Agreement by and between the Company and the Lender, dated September 18, 2017. At any time until the maturity date, and provided Lender gives the Company written notice of Lender’s election to convert prior to any prepayment of this Note by the Company with respect to converting that portion of this Note covered by the prepayment, the Lender has the right to convert all or any portion of the outstanding principal and accrued interest (the “Conversion Amount”), into such number of shares of the Company’s common stock as is determined by dividing the Conversion Amount by the greater of (i) seven dollars and fifty cents ($7.50) or (ii) 75% of the Volume Weighted Average Price of the Company’s common stock that is quoted on a public securities trading market (if more than one, the one with the then highest trading volume), during the five (5) consecutive trading days immediately prior to the date of the Lender’s written notice of its election to convert. As additional consideration for the loan evidenced by the Note, the Company agreed to issue to the Lender common stock purchase warrants exercisable for a period of three years from the date of issuance with an exercise price equal to $7.50 per share. The number of warrants issuable to the Lender is equal to 25% of the loan Amount divided by seven dollars and fifty cents ($7.50). As of September 18, 2017, the Company issued warrants to purchase up to 50,000 shares of common stock under this provision with a $7.50 exercise price having a fair value of $187,142 using the Black-Scholes valuation methodology. As a result of this transaction, the Company recorded $232,767 of debt discount consisting of the relative fair value of the warrants of $166,384 and a beneficial conversion feature of $66,384, which was amortized to interest expense over the original term of the note. During any time when the Note is outstanding, or when the Lender holds any Company stock, or any warrants to acquire Company stock where the combination of both could result in the Lender owning stock with a current value of one million dollars or greater, in the Company, the Lender will have certain review and consulting rights as described in the Note. As of March 31, 2019, the convertible note had a balance, net of discount of $215,450, amounting to $1,284,550 with accrued interest amounting to $16,774. During the quarter ended June 30, 2019, the Company repaid the note balance of $1,500,000, unpaid interest of $22,029, of which $5,255 of interest was expensed in that quarter.

8. NOTE PAYABLE

8. NOTE PAYABLE	9 Months Ended
	Sep. 30, 2019
Notes Payable [Abstract]
NOTE PAYABLE	8. NOTE PAYABLE During the quarter ended June 30, 2019, the Company used proceeds from its public offering to pay off the entire balance of this Notes Payable, along with all accrued and unpaid interest. As of September 30, 2019, the following summarizes this note payable: On August 27, 2018, the Company entered into an unsecured promissory note (the “Note”) in the amount of $750,000 (the “Principal Amount”) with Gemini Special Opportunities Fund, LP (“Gemini”). The Note bears simple interest at an annual rate of 10% and is subject to a Securities Purchase Agreement, dated August 27, 2018. This Note was due and payable on February 28, 2019 (the “Maturity Date”). Effective February 28, 2019, a forbearance agreement was granted by Gemini lender for any defaults, confirmed in writing, until Gemini and the Company complete an amendment extending the maturity date of the note, or the note is repaid by the Company. If the Company repays the Note after November 28, 2018, the Company shall pay 115% of the Principal Amount plus accrued interest. During the year ending December 31, 2018, the Company recorded an increase in the Note Payable balance of $112,500 with offsetting debt discount related to this repayment premium which is being amortized to interest expense over the term of the note. Additionally, the Company paid $5,000 of lender fees which were also recorded as debt discount and are also being amortized to interest expense over the term of the note. As additional consideration for the loan evidenced by the Note, the Company issued to Gemini warrants to purchase up to 18,000 shares of common stock for a period of five years from the date of issuance with an exercise price equal to $12.50 per share. These warrants had a fair value of $115,521 using the Black-Sholes valuation methodology. As a result of this transaction, the Company recorded $100,102 of debt discount consisting of the relative fair value of the warrants which is being amortized to interest expense over the term of the note. As of March 31, 2019, this note had a balance amounting to $862,500 with accrued interest amounting to $44,589. During the quarter ended June 30, 2019, the Company repaid the note balance of $862,500, and unpaid interest of $47,466, of which $2,877 was expensed in that quarter. In addition, the Company paid $75,000 for an extension fee, which was recorded as interest expense in that quarter.

9. AUTO LOAN

9. AUTO LOAN	9 Months Ended
	Sep. 30, 2019
Notes Payable [Abstract]
AUTO LOAN	9. AUTO LOAN In October 2015, the Company purchased a new vehicle and financed the purchase through a dealer auto loan. The loan has a term of 60 months, requires minimum monthly payments of approximately $950, and bears interest at a rate of 5.99 percent. As of September 30, 2019, the loan has a short-term portion of $11,014 and a long-term portion of $940.

10. COMMITMENTS AND CONTINGENCI

10. COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	10. COMMITMENTS AND CONTINGENCIES Legal Matters: From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. As of September 30, 2019, there were no pending or threatened lawsuits that could reasonably be expected to have a material effect on the results of our operations. Leases: In August 2016, the Company entered into a sublease for its current corporate headquarters and manufacturing facility. The sublease expires in August 2020 which is the same term of the master lease for which the Company is the subtenant. Monthly lease payments range from $48,672 per month currently increasing to $50,619 per month for the final year of the lease. In February 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-02: “Leases (Topic 842)” whereby lessees need to recognize almost all leases on their balance sheet as a right of use asset and a corresponding lease liability. The Company adopted this standard as of January 1, 2019 using the effective date method. We calculated the present value of the remaining lease payment stream using our incremental effective borrowing rate of 10%. We initially recorded a right to use asset and corresponding lease liability amounting to $872,897 on January 1, 2019. The right to use asset and the corresponding lease liability are being equally amortized on a straight-line basis over the remaining term of the lease. The right to use asset has been further reduced by our deferred rent amounting to $45,059 as of September 30, 2019. As of September 30, 2019, we have a right-of-use asset amounting to $435,035 recorded in Property Plant and Equipment, and corresponding liability in Accrued Expenses amounting to $480,094 related to this lease (See Note 4). Other Commitments: The Company enters into various contracts or agreements in the normal course of business whereby such contracts or agreements may contain commitments. Since inception, the Company entered into agreements to act as a reseller for certain vendors; joint development contracts with third parties; referral agreements where the Company would pay a referral fee to the referrer for business generated; sales agent agreements whereby sales agents would receive a fee equal to a percentage of revenues generated by the agent; business development agreements and strategic alliance agreements where both parties agree to cooperate and provide business opportunities to each other and in some instances, provide for a right of first refusal with respect to certain projects of the other parties; agreements with vendors where the vendor may provide marketing, investor relations, public relations, technical consulting or subcontractor services, vendor arrangements with non-binding minimum purchasing provisions, and financial advisory agreements where the financial advisor would receive a fee and/or commission for raising capital for the Company. All expenses and liabilities relating to such contracts were recorded in accordance with generally accepted accounting principles during the periods. Although such agreements increase the risk of legal actions against the Company for potential non-compliance, there were no financial exposures that were not accounted for in our financial statements.

11. COMMON STOCK

11. COMMON STOCK	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
COMMON STOCK	11. COMMON STOCK Stock Issued in Cash Sales During the three months ended June 30, 2019, the Company closed an underwritten public offering with Maxim Group LLC (“Maxim”), as representative for the several underwriters (the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters an aggregate of 2,000,000 units with each unit consisting of one (1) share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and a warrant to purchase one (1) share of Common Stock at an exercise price equal to $6.30 per share (the “Warrants”). In addition, the Company granted the Underwriters a 45-day option to purchase up to 300,000 additional shares of Common Stock, or Warrants, or any combination thereof, at the public offering price to cover over-allotments, if any. The Common Stock and the Warrants were offered and sold to the public (the “Offering”) pursuant to the Company’s registration statement on Form S-1 (File Nos. 333-226040), filed by the Company with the Securities and Exchange Commission (the “Commission”) on July 2, 2018, as amended, which became effective on April 15, 2019, and a related registration statement filed pursuant to Rule 462 promulgated under the Securities Act of 1933, as amended (the “Securities Act”). The offering price to the public was $6.00 per unit and the Underwriters purchased 2,000,000 units. In addition, the Underwriters purchased 300,000 Warrants for $3,000 upon the exercise of the Underwriters’ over-allotment option. The Company received gross proceeds of approximately $12,003,000, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, on May 15, 2019, the Company sold 200,000 shares of common stock in accordance with the terms of the Underwriting Agreement in connection with the partial exercise of the over-allotment option granted to the Underwriters (the “Over-allotment). The Company received gross proceeds of approximately $1,198,000, before deductions from the Over-allotment. The total expenses of the offering were approximately $1,371,000. In addition, the underwriters were issued 110,000 warrants as a fee based on 5% of total shares sold. Reverse Stock Split In April 2019, the Company effected a one-for-fifty reverse split of its issued and outstanding common stock (the “Reverse Stock Split”) and reduced the number of authorized shares of common stock from 490,000,000 to 9,800,000. No fractional shares were issued as a result of the Reverse Stock Split. Fractional shares were rounded up or down to the nearest whole share, after aggregating all fractional shares held by a stockholder, resulting in the issuance of 187 round-up shares. Any stockholder holding less than 24 shares of Common Stock on a pre-reverse stock basis were paid in cash for such fractional share of Common Stock, which totaled $171. All share and per share data in the accompanying unaudited financial statements and footnotes for all periods presented have been retroactively adjusted for this Reverse Stock Split. Director Compensation During the nine months ended September 30, 2019, the Company issued a total of 25,000 shares of common stock to two directors that vested from restricted stock grants dated January 1, 2017, whereby each director was granted 15,000 shares that vest on a pro rata basis over a three year period (which represents 7,500 of these shares) and 15,000 shares that vest based on performance criteria (which represents 17,500 of these shares). The pro rata shares have a per share fair value of $7.50, or $56,250 (based on the market price at the time of the agreement) and the performance shares have a per share fair value of $5.50, or $96,250 (based on the market price on September 17, 2019, which is the date of grant based on when the performance criteria was defined). Additionally, during the nine months ended September 30, 2019, the Company issued 8,750 shares of common stock to one director that vested from restricted stock grants dated August 21, 2018, whereby the director was granted 15,000 shares that vest on a pro rata basis over a three year period (which represents 3,750 of these shares) and 15,000 shares that vest based on performance criteria (which represents 5,000 of these shares). The pro rata shares have a per share fair value of $10.00, or $37,500 (based on the market price at the time of the agreement) and the performance shares have a per share fair value of $5.50, or $27,500 (based on the market price on September 17, 2019, which is the date of grant based on when the performance criteria was defined). As of September 30, 2019, there were 25,000 unvested and unissued shares of common stock representing $118,750 of unrecognized restricted stock grant expense related to these Restricted Stock Grant Agreements. On September 17, 2019, the Board of Directors (the “Board”), upon the recommendation of its Compensation Committee, and based on input from a third party, nationally recognized compensation consultant, approved the following directors’ compensation for non-employee directors of the Company: (1) a quarterly cash retainer of $2,500 to be paid retroactively as of April 1, 2019; (2) an annual grant of 12,500 shares of restricted stock to be issued under the Company’s 2011 Stock Incentive Plan (the “Plan”) annually on October 1 and which shall vest quarterly in four (4) equal installments; (3) a payment of $1,000 for attendance in person (or $500 for attendance telephonically) for regularly scheduled board meetings; and (4) to the independent lead director, who is currently Robert C. Schweitzer, an additional annual grant of 5,000 shares of restricted stock to be issued under the Plan annually on October 1 and which shall vest quarterly in four (4) equal installments. As a result of the above changes to the non-employee directors’ compensation, all unvested shares of restricted stock held by non-employee directors as of October 1, 2019 were cancelled. As a result of these changes, each director was paid $6,000 for retroactive and current board and meeting fees in the quarter ended September 30, 2019.

12. STOCK OPTIONS AND WARRANTS

12. STOCK OPTIONS AND WARRANTS	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
STOCK OPTIONS AND WARRANTS	12. STOCK OPTIONS AND WARRANTS Stock Options In the nine months ended September 30, 2019, an option was granted on July 23, 2019 to the Company’s Chief Financial Officer to purchase up to 49,104 shares of the Company’s common stock. These options will vest over 4 years and have an exercise price of $5.78 per share. The Company estimated the fair value of these options at $210,489 utilizing the Black-Scholes pricing model. The assumptions used in the valuation of these options include volatility of 82.26% based on historical volatility, expected dividends of 0.0%, a discount rate of 1.92% and expected term of 7.0 years based on the simplified method. During the nine months ended September 30, 2019 and 2018, the Company recorded non-cash stock-based compensation of $12,092 and $13,026, respectively. As of September 30, 2019, there is $201,719 of unrecognized stock option-based compensation expense that will be recognized over the next four years. The number of options to purchase capital stock that were outstanding at September 30, 2019 was 288,662. During the nine months ended September 30, 2019, 29,650 options were forfeited due to terminations and 27,198 expired. Warrants As part of the Company’s public offering (see Note 11), the Company issued 2,300,000 warrants during the three months ended June 30, 2019 to the Underwriters. These warrants are exercisable for five years at an exercise price of $6.30 per share. In April 2019, pursuant to the Underwriting Agreement, the Company issued as a fee to the Underwriters warrants to purchase up to a total of 110,000 shares of common stock (5% of the shares of common stock sold). The warrants are exercisable at $6.60 per share and have a term of five years. There was no financial statement accounting effect for the issuance of these warrants. During the nine months ended September 30, 2019, 5,370 warrants expired. Total warrants outstanding at September 30, 2019 is shown in the table below: Number of Warrants Outstanding December 31, 2018 134,359 Public Offering 2,300,000 Underwriter Warrants 100,001 Over-Allotment Warrants for Underwriters 10,000 Expired (5,370 ) Outstanding September 30, 2019 2,538,990

13. REVENUES

13. REVENUES	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
REVENUES	13. REVENUES For each of the identified periods, revenues can be categorized into the following: For the nine months ended September 30, 2019 2018 Product Sales $ 4,607,237 $ 4,642,428 Maintenance Fees 8,432 5,682 Professional Services – 10,575 Total Revenues $ 4,615,669 $ 4,658,685 At September 30, 2019 and December 31, 2018, deferred revenue was $86,677 and $835,785 respectively. The September 30, 2019 balance includes an initial deposit to plan and manufacture two Solar Tree® units, in addition to deposits for multi-year maintenance plans for previously sold products. As of September 30, 2019, deferred revenue associated with product deposits are $26,304 and the delivery of such products are expected within the next six months, while deferred maintenance fees amounted to $60,373 and pertain to services to be provided through the third quarter of 2024. At December 31, 2018, the Company accrued expected contract losses of $71,744 on an order for a customer that was expected to ship in 2019 (see Note 4). As the units were delivered, the loss accrual was proportionally reduced. In the three and nine months ended September 30, 2019, $30,611 and $71,744 was released from the accrual to reduce cost of revenues.

14. SUBSEQUENT EVENTS

14. SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	14. SUBSEQUENT EVENTS On September 17, 2019, the Board, upon the recommendation of its Compensation Committee, granted two directors annual grants of 12,500 shares each, and the lead director was issued an annual grant of 17,500 shares, which vest quarterly in four (4) equal installments. The grant date was determined to be September 17, 2019 as that was when a mutual understanding of the key terms and conditions of the grants was reached. On the grant date, these shares had a per share fair value of $5.50 based on the quoted trading price, or $233,750. In addition, the Board approved two grants of restricted stock of the Company to Mr. Wheatley under the 2011 Stock Incentive Plan (the “Plan”). The total number of shares granted was determined based on an award of $150,000 divided by the per share quoted trading price on October 1, 2019. On the grant date, the shares had a per share fair value of $5.97 and 25,124 shares were granted. On October 1, 2019, 8,374 of these shares vested generating an expense of $50,000 on October 1, 2019.

1. NATURE OF OPERATIONS, BASI_2

1. NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations Envision Solar International, Inc., a Nevada corporation (hereinafter the “Company,” “us,” “we,” “our” or “Envision”) is a sustainable technology innovation company based in San Diego, California. Focusing on what we refer to as “Solar 3.0,” we invent, design, engineer, manufacture and sell solar powered products that enable vital and highly valuable services in locations where it is either too expensive or too impactful to connect to the utility grid, or where the requirements for electrical power are so important that grid failures, like blackouts, are intolerable. When competing with utilities or typical solar companies, we rely on our products’ ease of deployment, reliability, accessibility, and total cost of ownership, rather than producing the cheapest kilowatt hour with the help of subsidies. Envision’s products and proprietary technology solutions target three markets that are experiencing significant growth with annual global spending in the billions of dollars: · electric vehicle charging infrastructure; · out of home advertising platforms; and · energy security and disaster preparedness. The Company focuses on creating renewably energized, high-quality products for electric vehicle (“EV”) charging, outdoor media and branding, and energy security that are rapidly deployable and attractively designed.
Basis of Presentation	Basis of Presentation The interim unaudited condensed financial statements included herein have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission. In management’s opinion, all adjustments (consisting of normal recurring adjustments and reclassifications) necessary to present fairly our results of operations and cash flows for the three and nine months ended September 30, 2019 and 2018, and our financial position as of September 30, 2019, have been made. The results of operations for such interim periods are not necessarily indicative of the operating results to be expected for the full year. Certain information and disclosures normally included in the notes to the annual financial statements have been condensed or omitted from these interim financial statements. Accordingly, these interim unaudited condensed financial statements should be read in conjunction with the financial statements and notes thereto for the year ended December 31, 2018. The December 31, 2018 balance sheet is derived from those statements.
Reverse Stock Split	Reverse Stock Split The Company completed a 1 for 50 reverse split of our common stock in April 2019, and all share and per share data in the accompanying unaudited financial statements and footnotes for all periods presented have been retroactively adjusted for this reverse stock split.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying unaudited condensed consolidated financial statements include the allowance for doubtful accounts receivable, valuation of inventory and cost allocations, depreciable lives of property and equipment, estimates of loss contingencies, estimates of the valuation of initial right of use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of share-based expense, and the valuation allowance on deferred tax assets.
Concentrations	Concentrations Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist of cash and accounts receivable. The Company maintains its cash in banks and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts from inception through September 30, 2019. As of September 30, 2019, $4,885,821 of the Company’s cash deposits were greater than the federally insured limits. Major Customers For the three months ended September 30, 2019, revenues from two customers accounted for 62% and 14% of total revenues, and for the nine months ended September 30, 2019, revenues from two customers accounted for 49% and 24% of total revenues, with no other single customer accounting for more than 10% of revenues. At September 30, 2019, accounts receivable from three customers accounted for 47%, 25% and 14% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. For the three months ended September 30, 2018, revenues from three customers accounted for 33%, 20% and 19% of total revenues, and for the nine months ended September 30, 2018, revenues from one customer accounted for 43%, with no other single customer accounting for more than 10% of revenues. At September 30, 2018, accounts receivable from three customers accounted for 42%, 25% and 13% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. Major Suppliers The Company currently has one source from which it procures its batteries for use in its products. To help mitigate the risk of supply or quality issues that could impact production, the Company has identified additional sources of supply and is qualifying them for use in the future to mitigate any supply risk.
Cash and Cash Equivalents	Cash and Cash Equivalents For the purposes of the unaudited condensed statements of cash flows, the Company considers all liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at September 30, 2019 and December 31, 2018 respectively.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s financial instruments, including accounts receivable, accounts payable, accrued expenses, and short-term loans, are carried at historical cost basis. At September 30, 2019, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.
Accounts Receivable	Accounts Receivable Accounts receivable are customer obligations due under normal trade terms. Management reviews accounts receivable on a periodic basis to determine if any receivables may become uncollectible. Management’s evaluation includes several factors including the aging of the accounts receivable balances, a review of significant past due accounts, dialogue with the customer, the financial profile of a customer, our historical write-off experience, net of recoveries, and economic conditions. The Company includes any accounts receivable balances that are determined to be uncollectible in its overall allowance for doubtful accounts. Further, the Company may record a general reserve in its allowance for doubtful accounts to account for future changes that may negatively impact our overall collections. After all attempts to collect a receivable have failed, the receivable is written off against the allowance.
Inventory	Inventory Inventory is stated at the lower of cost and net realizable value. Cost is determined using the first-in, first-out method of accounting. Inventory costs primarily relate to purchased raw materials and components used in the manufacturing of our products, work in process for products being manufactured, and finished goods. Included in these costs are direct labor and certain manufacturing overhead costs associated with the manufacturing process. The Company regularly reviews inventory components and quantities on hand and performs annual physical inventory counts. A reserve is established if this review process determines the net realizable value of such inventory may be below the carrying value.
Patents	Patents The Company believes it will achieve future economic value benefits for its various patents and patent ideas. All administrative costs for obtaining patents are accumulated on the balance sheet as a Patent asset until such time as a patent is issued. The costs of these intangible assets are classified as a long-term asset and amortized on a straight line basis over the legal life of such asset, which is typically 20 years. In the event a patent is denied or abandoned, all accumulated administrative costs will be expensed in the period in which the patent was denied or abandoned. Patent amortization expense was $2,397 and $856 in the nine-month periods ended September 30, 2019 and 2018, respectively.
Leases	Leases In February 2016, the Financial Accounting Standards Board issued Accounting Standards Update No. 2016-02: “Leases (Topic 842)” whereby lessees need to recognize almost all leases on their balance sheet as a right of use asset and a corresponding lease liability. The Company adopted this standard as of January 1, 2019 using the effective date method and applying the package of practical expedients to leases that commenced before the effective date whereby the Company elected not to reassess the following: (i) whether any expired or existing contracts contain leases, and (ii) initial direct costs for any existing leases. For contracts entered into after the effective date, at the inception of a contract the Company will assess whether the contract is, or contains, a lease. The Company’s assessment will be based on: (1) whether the contract involves the use of a distinct identified asset, (2) whether we obtain the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether it has the right to direct the use of the asset. The Company will allocate the consideration in the contract to each lease component based on its relative stand-alone price to determine the lease payments. The Company has elected to not recognize right of use assets and lease liabilities for short term leases that have a term of 12 months or less. Monthly lease payments on our sole operating lease range from $48,672 to $50,619 through the term of the lease. We calculated the present value of the remaining lease payment stream using our effective borrowing rate of 10%. We have recorded a right-of-use asset amounting to $435,035 included in property, plant and equipment and corresponding liability included in accrued expenses amounting to $480,094 related to this lease at September 30, 2019.
Revenue Recognition	Revenue Recognition On January 1, 2018, Envision adopted the revenue standards of Financial Accounting Standards Board Update No. 2014-09: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation. Revenues are primarily derived from the direct sales of manufactured products. Revenues may also consist of maintenance fees for the maintenance of previously sold products and revenues from sales of professional services. Revenues from inventoried product sales are recognized upon the final delivery of such product to the customer or when legal transfer of ownership takes place. Revenue values are fixed price arrangements determined at the time an order is placed or a contract is entered into. The customer is typically obligated to make payment for such products within a 30-45 day period after delivery. Revenues from maintenance fees for services provided by the Company are recognized equally over the period of the maintenance term. Revenue values are fixed price arrangements determined at the time an order is placed or a contract is entered into. The customer is typically obligated to make payment for the service in advance of the maintenance period. Extended maintenance or warranty services, where the customer has the option to purchase this extension as a separate purchase option, are considered a separate performance obligation. If the company does not control the extended services, in terms of having the responsibility for fulfillment of the obligation or the option to choose who will perform the services, the Company is acting as an agent and would report the revenues on a net basis. Revenues from professional services are recognized as services are performed. Revenue values are based upon fixed fee arrangements or hourly fee-based arrangements with agreed to hourly rates of service categories in line with expertise requirements. These services are billed to a customer as such services are provided and the customer will be obligated to make payments for such services typically within a 30-45 day period. The Company includes shipping and handling fees billed to customers as revenues and shipping and handling costs as cost of revenues. Any deposits received from a customer prior to delivery of the purchased product or monies paid prior to the period for which a service is provided are accounted for as deferred revenue on the balance sheet. Sales tax is recorded on a net basis and excluded from revenue. The Company generally provides a standard one-year warranty on its products for materials and workmanship but may provide multiple year warranties as negotiated, and it will pass on the warranties from its vendors, if any, which generally covers this one-year period. In accordance with ASC 450-20-25, the Company accrues for product warranties when the loss is probable and can be reasonably estimated. At September 30, 2019, the Company has no product warranty accrual given the Company’s de minimis historical financial warranty expense.
Cost of Revenues	Cost of Revenues The Company records direct material and component costs, direct labor and associated benefits, and manufacturing overhead costs such as supervision, manufacturing equipment depreciation, rent, and utility costs, all of which are included in inventory prior to a sale, as costs of revenues. The Company further includes shipping and handling fees billed to customers as revenues and shipping and handling costs as cost of revenues.
Stock-Based Compensation	Stock-Based Compensation The Company follows ASC 718, “Compensation – Stock Compensation.” ASC 718 requires companies to estimate and recognize the fair value of stock-based awards to employees and directors. The fair value of the portion of an award that is ultimately expected to vest is recognized as an expense over the shorter of the service periods or vesting periods using the straight-line attribution method. The Company adopted ASU 2018-07 and accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC 718 and recognizes the fair value of such awards over the service period. The Company used the modified prospective method of adoption. There was no cumulative effect of adoption on January 1, 2019. The Company estimates the fair value of each stock option at the grant date by using the Black-Scholes option pricing model.
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding during the periods presented. Diluted net loss per common share is computed using the weighted average number of common shares outstanding for the period, and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options, stock warrants, convertible debt instruments or other common stock equivalents. Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. Convertible notes payable that are convertible into 35,174 common shares, options to purchase 288,662 common shares and warrants to purchase 2,538,990 common shares were outstanding at September 30, 2019. These shares were not included in the computation of diluted loss per share for the three or nine months ended September 30, 2019 because the effects would have been anti-dilutive. These options, warrants and convertible debt embedded conversion options may dilute future earnings per share.
Segments	Segments The Company follows ASC 280-10 "Disclosures about Segments of an Enterprise and Related Information." During 2019 and 2018, the Company only operated in one segment; therefore, segment information has not been presented.

3. INVENTORY (Tables)

3. INVENTORY (Tables)	9 Months Ended
	Sep. 30, 2019
Inventory Disclosure [Abstract]
Schedule of inventory	September 30, December 31, 2019 2018 Work in process $ 783,314 $ 443,701 Raw materials 924,029 698,689 Inventory allowance (11,424 ) (11,424 ) Total inventory $ 1,695,919 $ 1,130,966

4. ACCRUED EXPENSES (Tables)

4. ACCRUED EXPENSES (Tables)	9 Months Ended
	Sep. 30, 2019
Payables and Accruals [Abstract]
Accrued expenses	September 30, December 31, 2019 2018 Lease liability $ 480,094 $ – Accrued vacation 169,061 196,888 Accrued salaries 100,141 – Accrued interest 43,389 239,838 Accrued rent – 66,349 Accrued loss contingency – 71,744 Other accrued expense 31,252 39,351 Total accrued expenses $ 823,937 $ 614,170

12. STOCK OPTIONS AND WARRANTS

12. STOCK OPTIONS AND WARRANTS (Tables)	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
Schedule of warrants	Number of Warrants Outstanding December 31, 2018 134,359 Public Offering 2,300,000 Underwriter Warrants 100,001 Over-Allotment Warrants for Underwriters 10,000 Expired (5,370 ) Outstanding September 30, 2019 2,538,990

13. REVENUES (Tables)

13. REVENUES (Tables)	9 Months Ended
	Sep. 30, 2019
Revenue from Contract with Customer [Abstract]
Schedule of revenues	For the nine months ended September 30, 2019 2018 Product Sales $ 4,607,237 $ 4,642,428 Maintenance Fees 8,432 5,682 Professional Services – 10,575 Total Revenues $ 4,615,669 $ 4,658,685

1. NATURE OF OPERATIONS, BASI_3

1. NATURE OF OPERATIONS, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Reverse stock split			In April 2019, the Company effected a one-for-fifty reverse stock split
Cash uninsured amount	$ 4,885,821		$ 4,885,821
Cash equivalents	$ 0		0		$ 0
Patent amortization			$ 2,397	$ 856
Lease borrowing rate	10.00%		10.00%
Right-of-use asset	$ 435,035		$ 435,035
Lease liability	$ 480,094		$ 480,094
Convertible Notes Payable [Member]
Antidilutive shares			35,174
Options [Member]
Antidilutive shares			288,662
Warrants [Member]
Antidilutive shares			2,538,990
Revenues [Member] | One Customer [Member]
Concentration percentage	62.00%	33.00%	49.00%	43.00%
Revenues [Member] | One Customer [Member]
Concentration percentage	14.00%	20.00%	24.00%
Revenues [Member] | One Customer [Member]
Concentration percentage		19.00%
Accounts Receivable [Member] | One Customer [Member]
Concentration percentage			47.00%	42.00%
Accounts Receivable [Member] | One Customer [Member]
Concentration percentage			25.00%	25.00%
Accounts Receivable [Member] | One Customer [Member]
Concentration percentage			14.00%	13.00%

2. LIQUIDITY (Details Narrative

2. LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Net loss	$ (610,363)	$ (983,874)	$ (949,631)	$ (606,556)	$ (774,271)	$ (1,011,607)	$ (2,543,868)	$ (2,392,434)
Net cash used in operating activities							(3,444,282)	(409,135)
Accumulated deficit	(44,419,527)						(44,419,527)		$ (41,875,659)
Net proceeds from sale of equity							13,201,000	0
Cash	$ 5,292,229			$ 254,940			5,292,229	$ 254,940	$ 244,024	$ 403,475
Equity Offering [Member]
Net proceeds from sale of equity							$ 8,500,000

3. INVENTORY (Details)

3. INVENTORY (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Work in Process	$ 783,314	$ 443,701
Raw Materials	924,029	698,689
Inventory Allowance	(11,424)	(11,424)
Total Inventory	$ 1,695,919	$ 1,130,966

4. ACCRUED EXPENSES (Details)

4. ACCRUED EXPENSES (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Lease liability	$ 480,094	$ 0
Accrued vacation	169,061	196,888
Accrued salaries	100,141	0
Accrued interest	43,389	239,838
Accrued rent	0	66,349
Accrued loss contingency	0	71,744
Other accrued expense	31,252	39,351
Total accrued expenses	$ 823,937	$ 614,170

5. CONVERTIBLE LINE OF CREDIT (

5. CONVERTIBLE LINE OF CREDIT (Details Narrative) - USD ($)	2 Months Ended	3 Months Ended				9 Months Ended			10 Months Ended	12 Months Ended
	Feb. 20, 2018	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 26, 2017	Oct. 24, 2017	Dec. 31, 2018
Repayment of line of credit						$ 960,000	$ 626,220
Convertible Line of Credit						0				$ 960,000
Revolver [Member]
Credit line maximum borrowing						$ 3,000,000
Credit line expiration date						Dec. 31, 2019
Revolver [Member] | Initial Draw Down [Member]
Proceeds from line of credit								$ 850,000
Warrants issued								28,333
Warrants issued fair value								$ 122,992
Beneficial conversion features								$ 243,223
Repayment of line of credit					$ 850,000
Revolver [Member] | Second Draw Down [Member]
Proceeds from line of credit									$ 300,000
Warrants issued									10,000
Warrants issued fair value									$ 56,620
Beneficial conversion features									$ 175,261
Repayment of line of credit					$ 300,000
Revolver [Member] | Third Drawdown [Member]
Proceeds from line of credit	$ 290,000
Warrants issued	8,156
Warrants issued fair value	$ 61,282
Beneficial conversion features	161,829
Repayment of line of credit				$ 290,000
Unamortized discount	$ 212,420
Revolver [Member] | Other Drawdowns [Member]
Proceeds from line of credit			$ 158,442							1,513,013
Repayment of line of credit		$ 1,118,442	0							553,013
Interest expense		9,893
Interest expense paid		$ 44,599
Convertible Line of Credit [Member]
Convertible Line of Credit			1,118,442			$ 0				960,000
Accrued interest			$ 34,705			$ 0				$ 12,909

6. CONVERTIBLE NOTE PAYABLE -_2

6. CONVERTIBLE NOTE PAYABLE - RELATED PARTY (Details Narrative) - Convertible Note - Related Party [Member] - Wheatley [Member] - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2019	Mar. 31, 2019	Dec. 31, 2018
Debt discount for beneficial conversion feature	$ 0	$ 3,967	$ 8,672
Convertible note payable related party balance outstanding	212,929
Bonus granted	35,000
Unamortized discount	7,488
Accrued interest	$ 43,389

7. CONVERTIBLE NOTES PAYABLE (D

7. CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
	Jun. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Mar. 31, 2019	Dec. 31, 2018	Jun. 27, 2018
Convertible note balance		$ 0			$ 1,104,235
Repayment of convertible note		1,650,616	$ 9,000
Pegasus Note [Member]
Convertible note balance		0		$ 100,000
Accrued and unpaid interest				92,603
Repayment of convertible note	$ 100,000
Interest paid	93,096
Interest expensed during period	493
Evey Note [Member]
Convertible note balance		$ 0		42,876
Unamortized discount				7,740		$ 30,960
Accrued and unpaid interest				76,440
Repayment of convertible note	50,616
Interest paid	77,066
Interest expensed during period	627
Strategic advisory services	80,000
Lender Note [Member]
Convertible note balance				1,284,550
Unamortized discount				215,450
Accrued and unpaid interest				$ 16,774
Repayment of convertible note	1,500,000
Interest paid	22,029
Interest expensed during period	$ 5,255

8. NOTE PAYABLE (Details Narrat

8. NOTE PAYABLE (Details Narrative) - USD ($)	3 Months Ended	8 Months Ended	9 Months Ended		12 Months Ended
	Jun. 30, 2019	Aug. 27, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Mar. 31, 2019
Amortized of debt discount			$ 524,925	$ 651,638
Note Payable			0		$ 788,185
Accrued interest			43,389		239,838
Note Payable [Member]
Debt issuance date		Aug. 27, 2018
Debt original amount		$ 750,000
Debt interest rate		10.00%
Maturity Date		Feb. 28, 2019
Increase in note payable balance					112,500
Lender fees recorded as debt discount					$ 5,000
Warrants issued, shares					18,000
Fair value of warrants					$ 115,521
Amortized of debt discount					100,102
Note Payable			$ 0			$ 862,500
Unamortized discount					$ 74,315
Accrued interest						$ 44,589
Repayment of note payable	$ 862,500
Interest paid	47,466
Interest expensed	2,877
Extension fee paid	$ 75,000

9. AUTO LOAN (Details Narrative

9. AUTO LOAN (Details Narrative) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Auto loan current	$ 11,014	$ 10,520
Auto loan noncurrent	$ 940	$ 9,277
Auto Loan [Member]
Debt interest rate	5.99%
Auto loan current	$ 11,014
Auto loan noncurrent	$ 940

10. COMMITMENTS AND CONTINGEN_2

10. COMMITMENTS AND CONTINGENCIES (Details Narrative)	9 Months Ended
	Sep. 30, 2019USD ($)
Commitments and Contingencies Disclosure [Abstract]
Lease expiration date	Aug. 31, 2020
Operating lease effective borrowing rate	10.00%
Right of use asset	$ 435,035
Operating lease liability	$ 480,094

11. COMMON STOCK (Details Narra

11. COMMON STOCK (Details Narrative) - USD ($)	3 Months Ended	4 Months Ended		9 Months Ended
	Jun. 30, 2019	May 15, 2019	Apr. 18, 2019	Sep. 30, 2019	Sep. 30, 2018
Proceeds from sale of units				$ 13,201,000	$ 0
Payment of offering costs				$ 0	12,000
Reverse stock split				In April 2019, the Company effected a one-for-fifty reverse stock split
Proceeds from fractional shares				$ 171	0
Share-based compensation expense				$ 229,592	$ 219,277
Unvested and unissued shares of stock				25,000
Unrecognized restricted stock grant expense				$ 118,750
Compensation Agreement [Member] | Two Directors [Member] | Restricted Stock [Member]
Stock vested, shares				7,500
Share-based compensation expense				$ 56,250
Compensation Agreement [Member] | A Director [Member] | Restricted Stock [Member]
Stock vested, shares				3,750
Share-based compensation expense				$ 37,500
Performance Shares [Member] | Two Directors [Member] | Restricted Stock [Member]
Stock vested, shares				17,500
Share-based compensation expense				$ 96,250
Performance Shares [Member] | A Director [Member] | Restricted Stock [Member]
Stock vested, shares				5,000
Share-based compensation expense				$ 27,500
Underwriting Agreement [Member]
Unit description			One unit is one share of the Company's common stock and a warrant to purchase one share of Common Stock.
Units sold			2,000,000
Proceeds from sale of units			$ 12,003,000
Payment of offering costs	$ 1,371,000		$ 300,000
Warrants issued, shares			300,000
Proceeds from issuance of warrants			$ 3,000
Underwriting Agreement [Member] | Underwriter Warrants [Member]
Warrants issued, shares		110,000
Underwriting Agreement [Member] | Over-Allotment Option [Member]
Units sold		200,000
Proceeds from sale of units		$ 1,198,000

12. STOCK OPTIONS AND WARRANT_2

12. STOCK OPTIONS AND WARRANTS (Details - Warrants) - Warrants [Member]	9 Months Ended
	Sep. 30, 2019shares
Warrants outstanding, beginning balance	134,359
Warrants expired	(5,370)
Warrants outstanding, ending balance	2,538,990
Underwriter Warrants [Member]
Warrants issued	100,001
Public Offering [Member]
Warrants issued	2,300,000
Over-Allotment Option [Member]
Warrants issued	10,000

12. STOCK OPTIONS AND WARRANT_3

12. STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
	Jun. 30, 2019	Sep. 30, 2019	Sep. 30, 2018
Stock option expense		$ 12,092	$ 13,026
Options [Member]
Options granted during period		0
Stock option expense		$ 12,092	$ 13,026
Unrecognized stock option expense		$ 201,719
Unrecognized compensation expense amortization period		4 years
Options outstanding		288,662
Options forfeited		29,650
Options expired		27,198
Options [Member] | Chief Financial Officer [Member]
Options granted during period		49,104
Weighted average vesting period		4 years
Option exercise price		$ 5.78
Fair value of options granted		$ 210,489
Warrants [Member]
Warrants expired		5,370
Warrants [Member] | Underwriter Warrants [Member]
Warrants issued	2,300,000
Warrant term	5 years
Warrant exercise price	$ 6.30
Warrants [Member] | Underwriter Fee Warrants [Member]
Warrants issued	110,000
Warrant term	5 years
Warrant exercise price	$ 6.60

13. REVENUES (Details)

13. REVENUES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues	$ 1,785,724	$ 938,218	$ 4,615,669	$ 4,658,685
Product sales [Member]
Revenues			4,607,237	4,642,428
Maintenance fees [Member]
Revenues			8,432	5,682
Professional Services [member]
Revenues			$ 0	$ 10,575

13. REVENUES (Details Narrative

13. REVENUES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Deferred revenue	$ 86,677		$ 86,677		$ 835,785
Cost of revenues	1,444,887	$ 894,068	4,266,389	$ 4,561,501
Prior Contract Accrual [Member]
Cost of revenues	30,611		71,744
Product Deposits [Member]
Deferred revenue	26,304		26,304
Maintenance Fees [Member]
Deferred revenue	$ 60,373		$ 60,373